BARCLAYS PLC

Position in GALT — Galectin Therapeutics Inc

CIK 312069 LONDON, X0

Position in GALT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$312,055

-$130,572 QoQ

Shares Held

111,848

+5.1% QoQ

Ownership

0.170%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. GALT ranks #186 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$312,055	111,848	+5.1%	Shares	Defined	2026-05-15
2025-12-31	$442,627	106,401	+1040.9%	Shares	Sole	2026-02-13
2025-03-31	$11,377	9,326	-82.9%	Shares	Sole	2026-03-17
2024-12-31	$70,476	54,634	+91.1%	Shares	Sole	2026-03-19
2024-09-30	$78,614	28,587	+309.0%	Shares	Sole	2026-03-31
2024-06-30	$15,795	6,989	+190.4%	Shares	Sole	2026-03-23
2021-09-30	$9,339	2,407	-63.6%	Shares	Sole	2021-11-09
2021-06-30	$21,142	6,607	-78.8%	Shares	Sole	2021-08-13
2021-03-31	$67,473	31,094	+159.0%	Shares	Sole	2021-05-13
2020-12-31	$26,893	12,006	-30.5%	Shares	Sole	2021-02-11
2020-09-30	$46,137	17,280	-17.9%	Shares	Sole	2020-11-12
2020-06-30	$64,415	21,051	+57.3%	Shares	Sole	2020-08-12
2020-03-31	$26,228	13,382	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.